台股 » 個股 » 訊聯 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

訊聯

(1784)
可現股當沖
  • 股價
    92.8
  • 漲跌
    ▼0.5
  • 漲幅
    -0.54%
  • 成交量
    260
  • 產業
    上櫃 生技醫療類股
  • 119人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
訊聯 (1784)籌碼相關-永豐金-三民 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-三民 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/05/10135.8000.0036.2511,6320.06%
2019/05/0600.00139.0539.05-11,639-0.06%
2019/04/2400.00140.8039.10-11,630-0.06%
2019/04/23141.251040.5040.80-91,697-0.53%
2019/04/2200.001539.4038.75-151,630-0.92%
2019/04/1600.00137.0039.10-11,822-0.05%
2019/04/12136.3000.0036.5011,8500.05%
2019/04/0900.00137.7537.10-11,860-0.05%
2019/04/0300.00136.1536.50-11,813-0.06%
2019/04/01135.1000.0034.5011,7780.06%
2019/03/13137.45138.0037.4001,6890.00%
2019/03/081037.6000.0037.50101,7200.58%
2019/03/05136.60136.7536.6001,7040.00%
2019/02/20538.40138.4539.0041,5940.25%
2019/02/1800.00139.1039.00-11,554-0.06%
2019/02/155739.095539.3438.8021,5120.13%
2019/02/14137.40136.2537.4501,3770.00%
2019/02/1100.00135.2034.90-11,266-0.08%
2019/01/291033.2500.0033.00101,2300.81%
2019/01/25133.1000.0033.1511,1940.08%
2019/01/2400.00133.6033.85-11,180-0.08%
2019/01/15235.3800.0034.8021,0360.19%
2019/01/1400.00134.4035.00-1971-0.10%
2019/01/1100.00133.3534.20-1956-0.10%
2019/01/101334.221434.8134.40-1929-0.11%
2019/01/09333.4700.0034.1039240.32%
2018/12/0500.00127.8027.10-11,459-0.07%
2018/12/04126.3000.0026.0011,5290.07%
2018/11/3000.00126.8025.90-11,742-0.06%
2018/11/20225.08224.6024.5501,6440.00%
2018/11/0800.00124.1524.15-11,609-0.06%
2018/11/0700.00223.9523.90-21,596-0.13%
2018/10/24125.2500.0025.3511,5460.06%
2018/10/1500.00123.3523.00-11,369-0.07%
2018/10/12222.4500.0022.9021,3560.15%
2018/10/0500.00129.8528.30-11,285-0.08%
2018/10/04330.0800.0029.9031,2530.24%
2018/09/19234.60233.8033.0001,0270.00%
2018/09/18132.9000.0034.0519270.11%
2018/09/1100.00131.7532.10-1624-0.16%
2018/09/1000.00232.6832.75-2476-0.42%
2018/09/07131.2500.0029.8013560.28%
2018/02/0500.00126.9526.95-1192-0.52%
2018/02/02129.2000.0027.8011870.53%
訊聯H1外泌體業績年增1.8倍 旗下訊聯細胞智藥擬Q4登興櫃Anue鉅亨-2024/08/26
〈亞洲生技大會〉訊聯全球研發代工商模發表成功案例 攜手搶攻兆元商機Anue鉅亨-2024/07/26
【鑫攻略早報】訊聯、訊聯基因再飆漲停創高!生技再起?Anue鉅亨-2024/07/19
訊聯 相關文章
訊聯 相關影音